Cipla has launched Leuprolide Acetate Injection Depot 225mg The product was approved by the United States Food and Drug Administration US FDA based on a New Drug Application NDA submitted under the 505b2 regulatory pathway Leuprolide Acetate Injection Depot contains 225 mg of leuprolide acetate for 3-month administration given as a single dose injection It is supplied as lyophilized microspheres in a single dose vial as a kit with a prefilled syringe containing 2mL 08Percentage mannitol solution and an easy-to-use MIXJECT transfer device for a single dose injection It is indicated for palliative treatment of advanced prostate cancer The active ingredient route of administration dosage form and strength are the same as LUPRON DEPOT 225 mg strength from Abbvie According to IQVIA LUPRON DEPOT 225mg had US sales of approximately $197M for the 12-month period ending September 2022
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.